Free Trial

Nanobiotix (NBTX) Short Interest Ratio & Short Volume

$5.00
-0.05 (-0.99%)
(As of 10/10/2024 ET)

Nanobiotix Short Interest Data

Nanobiotix (NBTX) has a short interest of 33,300 shares. This marks a -17.98% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 13,134 shares to cover all short positions.

Current Short Interest
33,300 shares
Previous Short Interest
40,600 shares
Change Vs. Previous Month
-17.98%
Dollar Volume Sold Short
$191,475.00
Short Interest Ratio
3.5 Days to Cover
Last Record Date
September 30, 2024
Outstanding Shares
47,130,000 shares
Percentage of Shares Shorted
0.07%
Today's Trading Volume
763 shares
Average Trading Volume
13,134 shares
Today's Volume Vs. Average
6%
Short Selling Nanobiotix?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Nanobiotix and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NBTX Short Interest Over Time

NBTX Days to Cover Over Time

NBTX Percentage of Float Shorted Over Time

Nanobiotix Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202433,300 shares $191,475.00 -18.0%N/A3.5 $5.75
9/15/202440,600 shares $200,970.00 -19.4%N/A4.2 $4.95
8/31/202450,400 shares $302,400.00 -1.8%N/A6.2 $6.00
8/15/202451,300 shares $248,805.00 -0.8%N/A7 $4.85
7/31/202451,700 shares $280,214.00 +2.0%N/A7.5 $5.42
7/15/202450,700 shares $277,329.00 -9.8%N/A6.7 $5.47
6/30/202456,200 shares $281,000.00 -0.5%N/A2.1 $5.00
6/15/202456,500 shares $259,900.00 +2.4%N/A1.6 $4.60
5/31/202455,200 shares $388,608.00 +1.3%N/A1.6 $7.04
5/15/202454,500 shares $398,395.00 -2.2%N/A1.5 $7.31
4/30/202455,700 shares $325,288.00 +5.7%N/A1.5 $5.84
4/15/202452,700 shares $294,593.00 +4.8%N/A1.5 $5.59
3/31/202450,300 shares $326,944.97 +4.1%N/A2.6 $6.50
3/15/202448,300 shares $335,685.00 +12.1%N/A3.8 $6.95
2/29/202443,100 shares $269,375.00 +0.2%N/A2.3 $6.25
2/15/202443,000 shares $317,340.00 +2.4%N/A2.3 $7.38
1/31/202442,000 shares $319,200.00 -7.9%N/A2.2 $7.60
1/15/202445,600 shares $357,960.00 +27.7%N/A2.3 $7.85
12/31/202335,700 shares $259,896.00 +113.8%N/A1.9 $7.28
12/15/202316,700 shares $104,208.00 +138.6%N/A0.9 $6.24
11/30/20237,000 shares $39,235.00 -23.1%N/A0.6 $5.61
11/15/20239,100 shares $53,144.00 -24.8%N/A0.4 $5.84
10/31/202312,100 shares $79,255.00 -36.7%N/A0.3 $6.55
10/15/202319,100 shares $127,970.00 +6.1%N/A0.4 $6.70
9/30/202318,000 shares $157,500.00 -4.3%N/A0.2 $8.75
9/15/202318,800 shares $177,039.60 -21.3%0.1%0.1 $9.42
8/31/202323,900 shares $218,446.00 -15.6%0.1%0.1 $9.14
8/15/202328,300 shares $234,041.00 -38.9%0.1%0.1 $8.27
7/31/202346,300 shares $356,973.00 -62.2%0.1%0.2 $7.71
7/15/2023122,400 shares $779,688.00 +367.2%0.4%0.1 $6.37
6/30/202326,200 shares $135,716.00 -22.0%0.1%0 $5.18
6/15/202333,600 shares $172,368.00 -8.5%0.1%0 $5.13
5/31/202336,700 shares $168,086.00 -49.9%0.1%0.1 $4.58
5/15/202373,200 shares $343,308.00 +850.7%0.2%0.1 $4.69
4/30/20237,700 shares $16,478.00 +28.3%0.0%0 $2.14
4/15/20236,000 shares $23,700.00 -22.1%0.0%3.5 $3.95
3/31/20237,700 shares $27,142.50 +30.5%0.0%5.9 $3.53
3/15/20235,900 shares $20,467.69 No Change0.0%4.2 $3.47
2/28/20235,900 shares $20,768.00 +391.7%0.0%4.2 $3.52
2/15/20231,200 shares $4,428.00 -33.3%N/A0.8 $3.69
Elon knows the truth, which is why they want him silenced (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,
1/31/20231,800 shares $7,686.00 +50.0%0.0%1.3 $4.27
1/15/20231,200 shares $5,136.84 -55.6%N/A1 $4.28
12/30/20222,700 shares $9,909.00 +42.1%0.0%1.6 $3.67
12/15/20221,900 shares $7,600.00 -9.5%0.0%1 $4.00
11/30/20222,100 shares $8,295.00 -25.0%0.0%1.1 $3.95
11/15/20222,800 shares $11,634.00 +40.0%0.0%1.3 $4.16
10/31/20222,000 shares $7,920.00 -64.9%0.0%0.9 $3.96
10/15/20225,700 shares $20,007.00 -52.1%0.0%1.7 $3.51
9/30/202211,900 shares $42,126.00 +30.8%0.0%4.1 $3.54
9/15/20229,100 shares $38,675.00 +116.7%0.0%3.5 $4.25
8/31/20224,200 shares $16,758.00 -2.3%0.0%1.7 $3.99
8/15/20224,300 shares $19,608.00 +168.8%0.0%1.9 $4.56
7/31/20221,600 shares $3,712.00 -33.3%N/A0.8 $2.32
7/15/20222,400 shares $8,448.00 +33.3%0.0%3 $3.52
6/30/20221,800 shares $6,840.00 +63.6%0.0%2.3 $3.80
6/15/20221,100 shares $4,246.00 +10.0%N/A0.7 $3.86
5/31/20221,000 shares $5,230.00 No ChangeN/A0.7 $5.23
5/15/20221,000 shares $5,266.00 -44.4%N/A0.6 $5.27
4/30/20221,800 shares $10,620.00 +100.0%0.0%0.6 $5.90
4/15/2022900 shares $5,850.00 +12.5%N/A0.2 $6.50
3/31/2022800 shares $5,952.00 -38.5%N/A0.2 $7.44
3/15/20221,300 shares $8,528.00 +30.0%N/A0.2 $6.56
2/28/20221,000 shares $7,540.00 -9.1%N/A0.1 $7.54
2/15/20221,100 shares $9,878.00 -69.4%N/A0.1 $8.98
1/31/20223,600 shares $27,540.00 -26.5%0.0%0.5 $7.65
1/15/20224,900 shares $44,786.00 +345.5%0.0%1 $9.14
12/31/20211,100 shares $8,910.00 -8.3%N/A0.2 $8.10
12/15/20211,200 shares $8,928.00 -58.6%N/A0.3 $7.44
11/30/20212,900 shares $24,592.00 +16.0%0.0%0.7 $8.48
11/15/20212,500 shares $23,750.00 -64.8%0.0%1 $9.50
10/29/20217,100 shares $74,053.00 -36.6%0.0%3.4 $10.43
10/15/202111,200 shares $143,584.00 -0.9%0.0%4.9 $12.82
9/30/202111,300 shares $128,368.00 -11.7%0.0%4 $11.36
9/15/202112,800 shares $153,195.52 +392.3%0.0%5.8 $11.97
8/31/20212,600 shares $32,760.00 -27.8%0.0%1.2 $12.60
8/13/20213,600 shares $46,440.00 -73.1%0.0%1.3 $12.90
7/30/202113,400 shares $197,382.00 +19.6%0.0%4.6 $14.73
7/15/202111,200 shares $166,432.00 -11.1%N/A4.3 $14.86
6/30/202112,600 shares $173,628.00 No ChangeN/A6.6 $13.78
6/15/202112,600 shares $195,048.00 +31.3%N/A2.9 $15.48
5/28/20219,600 shares $164,352.00 -28.9%N/A2.1 $17.12
5/14/202113,500 shares $205,200.00 +60.7%N/A3 $15.20
4/30/20218,400 shares $133,728.00 -34.4%N/A1.4 $15.92
4/15/202112,800 shares $196,736.00 +85.5%N/A1.6 $15.37
3/31/20216,900 shares $104,742.00 -28.9%N/A0.6 $15.18
3/15/20219,700 shares $157,225.36 -32.2%N/A0.6 $16.21
2/26/202114,300 shares $237,094.00 -22.3%N/A0.4 $16.58
2/12/202118,400 shares $334,696.00 +11.5%N/A0.4 $18.19
1/29/202116,500 shares $287,100.00 -21.4%N/A0.3 $17.40
1/15/202121,000 shares $373,800.00 No ChangeN/A0.3 $17.80
Elon knows the truth, which is why they want him silenced (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

NBTX Short Interest - Frequently Asked Questions

What is Nanobiotix's current short interest?

Short interest is the volume of Nanobiotix shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 33,300 shares of NBTX short. Learn More on Nanobiotix's current short interest.

What is a good short interest ratio for Nanobiotix?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NBTX shares currently have a short interest ratio of 4.0. Learn More on Nanobiotix's short interest ratio.

Is Nanobiotix's short interest increasing or decreasing?

Nanobiotix saw a decline in short interest in the month of September. As of September 30th, there was short interest totaling 33,300 shares, a decline of 18.0% from the previous total of 40,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Nanobiotix's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nanobiotix: Phathom Pharmaceuticals, Inc. (29.42%), Wave Life Sciences Ltd. (4.56%), Immatics (11.25%), Cullinan Therapeutics, Inc. (23.62%), ArriVent BioPharma, Inc. (17.28%), Sana Biotechnology, Inc. (25.89%), AnaptysBio, Inc. (23.08%), Prothena Co. plc (9.86%), Phibro Animal Health Co. (1.96%), Applied Therapeutics, Inc. (10.82%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks.

What does it mean to sell short Nanobiotix stock?

Short selling NBTX is an investing strategy that aims to generate trading profit from Nanobiotix as its price is falling. NBTX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Nanobiotix?

A short squeeze for Nanobiotix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NBTX, which in turn drives the price of the stock up even further.

How often is Nanobiotix's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBTX, twice per month. The most recent reporting period available is September, 30 2024.




This page (NASDAQ:NBTX) was last updated on 10/11/2024 by MarketBeat.com Staff
From Our Partners